Hantavirus infection natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
 
(One intermediate revision by one other user not shown)
Line 10: Line 10:
*Hemodynamic compromise occurs a median of 5 days after symptom onset--usually dramatically within the first day of hospitalization.  
*Hemodynamic compromise occurs a median of 5 days after symptom onset--usually dramatically within the first day of hospitalization.  
*In contrast to HFRS, overt hemorrhage occurs rarely in HPS, although [[hemorrhage]] is occasionally seen in association with disseminated intravascular coagulation.
*In contrast to HFRS, overt hemorrhage occurs rarely in HPS, although [[hemorrhage]] is occasionally seen in association with disseminated intravascular coagulation.
*If left untreated it may cause multiple organ failure and death.
*If left untreated hantavirus infection may cause multiple organ failure and death.
 
==Complications==
==Complications==
Complications that can develop as a result of Hantavirus infection depends on the type of infection and can be summarized in the following table.<ref name="pmid28120221">{{cite journal |vauthors=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X |title=Hantavirus infection: a global zoonotic challenge |journal=Virol Sin |volume=32 |issue=1 |pages=32–43 |year=2017 |pmid=28120221 |doi=10.1007/s12250-016-3899-x |url=}}</ref>
Complications that can develop as a result of Hantavirus infection depends on the type of infection and can be summarized in the following table.<ref name="pmid28120221">{{cite journal |vauthors=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X |title=Hantavirus infection: a global zoonotic challenge |journal=Virol Sin |volume=32 |issue=1 |pages=32–43 |year=2017 |pmid=28120221 |doi=10.1007/s12250-016-3899-x |url=}}</ref>
Line 49: Line 50:
[[Category:Viral diseases]]
[[Category:Viral diseases]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]

Latest revision as of 17:53, 18 September 2017

Hantavirus infection Microchapters

Home

Patient Information

Hantavirus cardiopulmonary syndrome (HCPS) (patient information)
Hemorrhagic fever with renal syndrome (HFRS) (patient information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hantavirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future Investigational Therapies

Case Studies

Case #1

Hantavirus infection natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hantavirus infection natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hantavirus infection natural history, complications and prognosis

CDC on Hantavirus infection natural history, complications and prognosis

Hantavirus infection natural history, complications and prognosis in the news

Blogs on Hantavirus infection natural history, complications and prognosis

Directions to Hospitals Treating Hantavirus pulmonary syndrome

Risk calculators and risk factors for Hantavirus infection natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2], Aditya Ganti M.B.B.S. [3]

Overview

If hantavirus infection left untreated, it may result in multi-organ failure and death. Possible complications include, acute encephalomyelitis, Pituitary hemorrhage, Glomerulonephritis, Pulmonary edema, acute respiratory distress syndrome, Disseminated intravascular coagulation, Thrombocytopenia, and shock. Its prognosis depends on the extent of the diseases. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate but, hemorrhagic fever with renal syndrome (HFRS) has a better prognosis with 1 to 15% mortality rate.[1][2][3]

Natural History

  • Within 24 hours of initial evaluation, most patients develop some degree of hypotension and progressive evidence of pulmonary edema and hypoxia, usually requiring mechanical ventilation.
  • The patients with fatal infections appear to have severe myocardial depression which can progress to sinus bradycardia with subsequent electromechanical dissociation, ventricular tachycardia or fibrillation.
  • Hemodynamic compromise occurs a median of 5 days after symptom onset--usually dramatically within the first day of hospitalization.
  • In contrast to HFRS, overt hemorrhage occurs rarely in HPS, although hemorrhage is occasionally seen in association with disseminated intravascular coagulation.
  • If left untreated hantavirus infection may cause multiple organ failure and death.

Complications

Complications that can develop as a result of Hantavirus infection depends on the type of infection and can be summarized in the following table.[4]

Type of hantavirus infection Complications
Hemorrhagic fever with renal syndrome (HFRS)
Hantavirus cardiopulmonary syndrome (HCPS)

Prognosis

The overall prognosis of hantavirus infection depends on the clinical syndrome. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate. Hemorrhagic fever with renal syndrome (HFRS) has better prognosis than hantavirus cardiopulmonary syndrome (HCPS). Depending upon which virus is causing the HFRS, death occurs in less than 1% to as many as 15% of patients. Fatality ranges from 5-15% for HFRS caused by Hantaan virus, and it is less than 1% for disease caused by Puumala virus.[1][2][3]

References

  1. 1.0 1.1 Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW, Cappon J, Krahling JB, Wernly J (1998). "Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation". Crit. Care Med. 26 (2): 409–14. PMID 9468181.
  2. 2.0 2.1 Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA (2006). "Diagnosis and treatment of new world hantavirus infections". Curr. Opin. Infect. Dis. 19 (5): 437–42. doi:10.1097/01.qco.0000244048.38758.1f. PMID 16940866.
  3. 3.0 3.1 Levy H, Simpson SQ (1994). "Hantavirus pulmonary syndrome". Am. J. Respir. Crit. Care Med. 149 (6): 1710–3. doi:10.1164/ajrccm.149.6.8004332. PMID 8004332.
  4. Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X (2017). "Hantavirus infection: a global zoonotic challenge". Virol Sin. 32 (1): 32–43. doi:10.1007/s12250-016-3899-x. PMID 28120221.

Template:WH Template:WikiDoc Sources